Endosymbiont aids pathogenic fungi

Laila Partida-Martinez and Christian Hertweck of the Leibniz Institute for Natural Products Research and Infection Biology, Jena, Germany, demonstrated that rhizoxin, a plant-rotting toxin believed to come from pathogenic fungi in the genus Rhizopus is in fact synthesized by an endosymbiotic bacterium.1 They posit that the relationship confers a metabolic benefit to both to bacteria and its fungal host, giving each access to nutrients released by decaying plant material after infection.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Laila Partida-Martinez and Christian Hertweck of the Leibniz Institute for Natural Products Research and Infection Biology, Jena, Germany, demonstrated that rhizoxin, a plant-rotting toxin believed to come from pathogenic fungi in the genus Rhizopus is in fact synthesized by an endosymbiotic bacterium.1 They posit that the relationship confers a metabolic benefit to both to bacteria and its fungal host, giving each access to nutrients released by decaying plant material after infection.

Microbiologist June Kwon-Chung of the National Institute of Allergy and Infectious Diseases says that this is the first example in fungi of a toxin-producing bacterial symbiont.

?We know that virus existing within fungi can sometimes act to help the fungus become more or less virulent, but bacterial toxins helping fungi to invade the host is very rare and new. So it opened my eyes. What if deadly diseases in humans caused by Zygomycetes, the fungal phylum that includes all ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies